Related Experiment Video
Updated: Jun 27, 2025
Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy
Published on: May 8, 2018
Targeting Heme Oxygenase 2 (HO2) with TiNIR, a Theragnostic Approach for Managing Metastatic Non-Small Cell Lung
Seul-Ki Mun1,2, Hyun Bo Sim1, Jae-Hyuk Lee3
1Department of Biomedical Science, Sunchon National University, Suncheon 57922, Republic of Korea.
Abstract:
Despite notable advancements in cancer therapeutics, metastasis remains a primary obstacle impeding a successful prognosis. Our prior study has identified heme oxygenase 2 (HO2) as a promising therapeutic biomarker for the aggressive subsets within tumor. This study aims to systematically evaluate HO2 as a therapeutic target of cancer, with a specific emphasis on its efficacy in addressing cancer metastasis. Through targeted inhibition of HO2 by TiNIR (tumor-initiating cell probe with near infrared), we observed a marked increase in reactive oxygen species. This, in turn, orchestrated the modulation of AKT and cJUN activation, culminating in a substantial attenuation of both proliferation and migration within a metastatic cancer cell model. Furthermore, in a mouse model, clear inhibition of cancer metastasis was unequivocally demonstrated with an HO2 inhibitor administration. These findings underscore the therapeutic promise of targeting HO2 as a strategic intervention to impede cancer metastasis, enhancing the effectiveness of cancer treatments.
Insights
Targeting heme oxygenase 2 (HO2) with inhibitors significantly reduces cancer metastasis by increasing reactive oxygen species and modulating key signaling pathways. This approach shows therapeutic promise for aggressive cancers.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Cancer metastasis remains a significant challenge in patient prognosis despite therapeutic advancements.
- Heme oxygenase 2 (HO2) has been identified as a potential therapeutic biomarker in aggressive cancers.
Purpose of the Study:
- To systematically evaluate heme oxygenase 2 (HO2) as a therapeutic target for cancer.
- To assess the efficacy of HO2 inhibition in combating cancer metastasis.
Main Methods:
- Targeted inhibition of HO2 using TiNIR (tumor-initiating cell probe with near infrared).
- Assessment of reactive oxygen species (ROS) levels.
- Analysis of AKT and cJUN activation pathways.
- Evaluation in metastatic cancer cell models and a mouse model.
Main Results:
- HO2 inhibition led to increased reactive oxygen species (ROS).
- Modulation of AKT and cJUN activation was observed.
- Significant attenuation of cancer cell proliferation and migration.
- Clear inhibition of cancer metastasis in a mouse model.
Conclusions:
- Targeting HO2 is a promising therapeutic strategy to impede cancer metastasis.
- HO2 inhibition enhances the effectiveness of cancer treatments by addressing aggressive tumor subsets.
More Related Videos
Related Concept Videos
02:57Targeted Cancer Therapies
There are several types of targeted therapies against...
02:49Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...